5.56
+0.502(+9.92%)
Currency In USD
Address
2401 South Foothill Drive
Salt Lake City, UT 84109
United States of America
Phone
801 438 1036
Sector
Healthcare
Industry
Medical - Devices
Employees
132
First IPO Date
July 12, 2017
| Name | Title | Pay | Year Born |
| Dwight H. Egan | Chairman & Chief Executive Officer | 411,667 | 1953 |
| Brian L. Brown | Chief Financial Officer & Company Secretary | 328,333 | 1976 |
| Richard David Abbott | President | 346,999 | 1972 |
| Mayuranki Almaula | Senior Vice President of Overseas Operations & Strategic Alliances | 0 | N/A |
| Andrew Benson | Head of Investor Relations | 0 | N/A |
| Christopher Thurston | Chief Technology Officer | 0 | N/A |
| Dan Bohrer | Vice President of Finance & Accounting | 0 | N/A |
| David Nielsen | Chief Operating Officer | 0 | N/A |
| Seth Egan | Chief Commercialization Officer | 0 | N/A |
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.